Abstract
Hexavalent chromium [Cr(VI)] is a common human carcinogen associated with lung cancer and other pulmonary diseases as exposure to excessive Cr(VI) induces malignant transformation in human lung epithelial cells. The mechanism underlying its carcinogenicity is unclear in terms of how it facilitates metastases. Cr(VI) compounds are reported to briefly promote cell migration in a concentration-dependent manner and oncogene liver kinase B1 (LKB1) was reduced in Cr(VI)-transformed cells. Overexpression of LKB1 in Beas-2B-Cr [Cr(VI) malignantly transformed Beas-2B cells] suppressed cell migration and invasion and inactivated FAK, Src, MMP-2, GSK3β, β-catenin, and HEF1, which contribute to cell migration and invasion. Silencing LKB1 with siRNA promoted migration and invasion, and activated these downstream proteins. Long-term exposure to Cr(VI) enhanced the migration and invasiveness of Beas-2B cells and reduced the expression of LKB1, while activating these proteins as mentioned above. Data suggest that LKB1 may regulate downstream proteins such as FAK, Src, MMP-2, GSK3β, β-catenin, and HEF1, and affect the migration and invasiveness of Beas-2B-Cr cells.
References
Jan 1, 1990·American Journal of Industrial Medicine·S Langård
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·M M Tomayko, C P Reynolds
Apr 1, 1986·Journal of Surgical Oncology·D M EuhusF E Johnson
Jan 15, 1998·Nature·A HemminkiL A Aaltonen
Apr 7, 2000·Carcinogenesis·S De Flora
Jul 14, 2000·American Journal of Industrial Medicine·H J GibbB C Rooney
Dec 4, 2003·Mutation Research·Travis J O'BrienSteven R Patierno
Jun 29, 2004·The Journal of Biological Chemistry·Young-Ae ChoiSuk-Hwan Baek
Nov 17, 2005·Oncogene·M NatarajanC L Gladson
Jun 30, 2007·Oncogene·M Sanchez-Cespedes
Aug 7, 2007·Nature·Hongbin JiKwok-Kin Wong
Sep 10, 2009·Cancer Research·Eugene IzumchenkoErica A Golemis
May 1, 2010·Chemico-biological Interactions·Kristen P NickensSusan Ceryak
Jun 15, 2010·Cancer Cell·Jill Slack-DavisSarah J Parsons
Jun 15, 2010·Cancer Cell·Julian CarreteroKwok-Kin Wong
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yijun GaoHongbin Ji
Jul 12, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xin WangXianglin Shi
Aug 6, 2011·Japanese Journal of Clinical Oncology·Atsushi OsoegawaYukito Ichinose
Oct 18, 2012·Cancer Research·Yan FengHongbin Ji
Jan 5, 2013·Biochimica Et Biophysica Acta·S E KorsseW van Veelen
Mar 23, 2013·Toxicology and Applied Pharmacology·Song-Ze DingAndrew J Hitron
May 28, 2013·Toxicology and Applied Pharmacology·Young-Ok SonXianglin Shi
Sep 12, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kai LiuWei-Yu Shen
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rong FangHongbin Ji
May 15, 2015·Gene·Elena ShagisultanovaErica A Golemis
Jul 30, 2015·Toxicology and Applied Pharmacology·Jian LuZhigang Tu
Jan 27, 2017·Anti-cancer Drugs·Zhongping ZhouJian Lu